BLOG

Promoting the healthy development of the medical testing and diagnostic industry


Good news! ave has been selected for the tenth batch of "Excellent Domestic Medical Equipment Product Catalog", with 18 fecal analyzers on the list!

2024-08-27

Recently, the official website of the Chinese Medical Equipment Association released the "Announcement on the Selection and Evaluation Results of the Tenth Batch of Excellent Domestic Medical Equipment Products Catalog".

Technology Serving Health: A delegation of 15 hospital representatives from overseas engaged in in-depth exchanges, exploring the new future of microscopic examination.

2024-07-25

In this sunny season, we welcome special guests – a delegation from 15 hospitals in Nepal. They have embarked on this hopeful and opportunistic journey with a yearning for new medical technologies. This visit is not only a cross-border exchange, but also a joint exploration of the future of medical technology.

AVE Technology uses technological innovation to drive product incubation and explores the in-vitro diagnostic track

2024-07-23

Previously, things like excrement and secretions were manually inspected, a process that was both dirty and tiring. To address this industry pain point, the company is committed to applying "artificial intelligence + machine vision technology + big data" to the morphological testing of clinical specimens in medical institutions, driving the industry's transition from manual to automated microscopic examination." This was stated by Ding Jianwen, chairman of AVE Technology, in an interview with a reporter from the Securities Daily.

AVE Technology uses technological innovation to drive product incubation and explores the in-vitro diagnostic track

2024-07-23

Previously, things like excrement and secretions were manually inspected, a process that was both dirty and tiring. To address this industry pain point, the company is committed to applying "artificial intelligence + machine vision technology + big data" to the morphological testing of clinical specimens in medical institutions, driving the industry's transition from manual to automated microscopic examination." This was stated by Ding Jianwen, chairman of Aiwei Technology, in an interview with a reporter from the Securities Daily.

< 1234 >